Apr 2022 $1 M No. 5 Under $2 million 1
GVB Biopharma: Raise no. 5, Apr 2022 × Investors in this round 1 investor had bought by the notice of May 19, 2022: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken $50,000
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $100,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Nevada People named in the notice Jack Feldman · Executive Officer, Director Phillip Swindells · Executive Officer, Director William Spiegel · Executive Officer, Director Theodore Swindells · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round TerraNova Capital Equities, Inc. (CRD 45097) · New York, New York Sold in AK, AL, AR, AZ, CA, CO, CT, FL, GA, HI, ID, IL, IN, KS, KY, LA, MA, MI, MN, MO, MS, MT, NC, NH, NJ, NM, NY, OH, OR, PA, SC, TX, UT, VA, VT, WA, WI Signed by Jonathan Staffeldt, General Counsel. Source: SEC Form D, newest notice filed May 19, 2022. Read the notice at the SEC .
debt, options SEC Jan 2022 $2 M No. 4 Under $2 million 2
GVB Biopharma: Raise no. 4, Jan 2022 × Investors in this round 2 investors had bought by the notice of Jan 19, 2022: 2 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken $50,000
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $25,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Nevada People named in the notice Jack Feldman · Executive Officer, Director Phillip Swindells · Executive Officer, Director William Spiegel · Executive Officer, Director Theodore Swindells · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round TerraNova Capital Equities, Inc. (CRD 45097) · New York, New York Sold in AK, AL, AR, AZ, CA, CO, CT, FL, GA, HI, ID, IL, IN, KS, KY, LA, MA, MI, MN, MO, MS, MT, NC, NH, NJ, NM, NY, OH, OR, PA, SC, TX, UT, VA, VT, WA, WI Signed by Jonathan Staffeldt, Chief Legal Officer. Source: SEC Form D, newest notice filed Jan 19, 2022. Read the notice at the SEC .
debt, options SEC Oct 2021 $2 M No. 3 Under $2 million 10
GVB Biopharma: Raise no. 3, Oct 2021 × Investors in this round 10 investors had bought by the notice of Nov 3, 2021: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken $25,000
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $100,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Nevada People named in the notice Jack Feldman · Executive Officer, Director Phillip Swindells · Executive Officer, Director William Spiegel · Executive Officer, Director Theodore Swindells · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round TerraNova Capital Equities, Inc. (CRD 45097) · New York, New York Sold in AK, AL, AR, AZ, CA, CO, CT, FL, GA, HI, ID, IL, IN, KS, KY, LA, MA, MI, MN, MO, MS, MT, NC, NH, NJ, NM, NY, OH, OR, PA, SC, TX, UT, VA, VT, WA, WI Signed by Jonathan Staffeldt, General Counsel. Source: SEC Form D, newest notice filed Nov 3, 2021. Read the notice at the SEC .
debt, options SEC Nov 2020 $8 M No. 2 $2 to $10 million 28
GVB Biopharma: Raise no. 2, Nov 2020 × Investors in this round 28 investors had bought by the notice of Nov 27, 2020: 28 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $8 M of $8 M offered; $0 M still to sell
Smallest investment taken $500,000
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $640,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Nevada People named in the notice Jack Feldman · Executive Officer, Director Phillip Swindells · Executive Officer, Director William Spiegel · Executive Officer, Director Theodore Swindells · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round M.S. Howells & Co. (CRD 104100) · Scottsdale, Arizona Sold in AZ, CA, CT, IN, NY, PA, TX TerraNova Capital Equities, Inc. (CRD 45097) · New York, New York Sold in AK, AL, AR, AZ, CA, CO, CT, FL, GA, HI, ID, IL, IN, KS, KY, LA, MA, MI, MN, MO, MS, MT, NC, NH, NJ, NM, NY, OH, OR, PA, SC, TX, UT, VA, VT, WA, WI Signed by Jonathan Staffeldt, General Counsel. Source: SEC Form D, newest notice filed Nov 27, 2020. Read the notice at the SEC .
equity, options SEC May 2020 $1 M No. 1 Under $2 million 1
GVB Biopharma: Raise no. 1, May 2020 × Investors in this round 1 investor had bought by the notice of May 27, 2020: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $3 M offered; $2 M still to sell
Smallest investment taken $50,000
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $300,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Nevada People named in the notice Jack Feldman · Executive Officer, Director Phillip Swindells · Executive Officer, Director William Spiegel · Executive Officer, Director Theodore Swindells · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round TerraNova Capital Equities, Inc. (CRD 45097) · New York, New York Sold in AK, AL, AR, AZ, CA, CO, CT, FL, GA, HI, ID, IL, IN, KS, KY, LA, MA, MI, MN, MO, MS, MT, NC, NH, NJ, NM, NY, OH, OR, PA, SC, TX, UT, VA, VT, WA, WI Signed by Jonathan Staffeldt, General Counsel. Source: SEC Form D, newest notice filed May 27, 2020. Read the notice at the SEC .
debt, options SEC